Publications Office of the EU
Romania-Câmpulung: Antineoplastic agents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Romania-Câmpulung: Antineoplastic agents

Overview
  • Awarded
    15/02/2019
  • Today
    04/10/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Spitalul Municipal Câmpulung Muscel
Place of performance
NUTS code: RO311 Argeş
Location of buyer
NUTS code: RO311 Argeş
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
1,116.00
Total final contract value (excluding VAT)
2,018,642.80 RON
Please consult each lot for details
Number of lots
46
Procedure details
Tender reference number
22829/19.11.2018
Description

Oncology medicines – antineoplasic.
The CA responds within 2 days of the deadline for submission of tenders/requests for clarification/or additional information. Number of days until which clarifications may be requested before the closing date for submission of tenders/applications: 3.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
RO311 Argeş
CPV code

33652100 - Antineoplastic agents

Lots (46)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.